Project Grant HT94252510787
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$564K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $506,785.00 to The University of Queensland to conduct research on "Predicting Early-Stage Melanoma at High Risk of Recurrence Through Multiomics Profiling." The award period runs from September 1, 2025, to August 31, 2028. This research aims to develop innovative approaches for early detection and risk assessment of melanoma, a critical medical...
This federal Project Grant award of $1,156,726.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of Queensland (UQ) in Australia. The objective of the research project is to predict early-stage melanoma at high risk of recurrence through multiomics profiling. The award has a performance period from September 1, 2025 to August 31, 2028. UQ, a leading Australian research university, has an extensive...
The Defense Health Agency awarded a $744,997 Project Grant to the University of Queensland in Australia under the Military Medical Research and Development program (CFDA 12.420). This grant, titled "DISCOVERING THERAPEUTIC VULNERABILITIES OF CIRCULATING MELANOMA CLUSTERS," provides funding for the university to conduct cutting-edge biomedical research on melanoma from June 1, 2024 through May 31, 2027. The University of Queensland, a leading research institution in Australia, has an...
The University of Queensland in Australia was awarded a $1,488,596 Project Grant from the Department of the Army Medical Command to support melanoma research from September 2022 through September 2025. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health issues. Under this award, The University of Queensland...
The University of Queensland in Australia was awarded a $744,744 USD project grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "Understanding the Role of Immature Myeloid Cells in Early Melanoma Establishment" from September 30, 2022 to September 29, 2025. Through this funding, researchers at The University of Queensland will investigate the role of immature myeloid...
This federal Project Grant award in the amount of $733,068.00 was issued by the Defense Health Agency to the University of Melbourne on September 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project titled "Investigating Transcript Diversity as a Driver of Melanoma Progression and Recurrence." The University of Melbourne will conduct basic, translational, and clinical research aimed at developing new...
This Project Grant from the Department of the Army Medical Command, totaling $530,887, supports research from September 1, 2022 to August 31, 2025 aimed at developing a multimodal precision liquid biopsy to predict risk of melanoma recurrence. Funded under the Military Medical Research and Development program (CFDA 12.420), the award supports Macquarie University in Australia to investigate medical solutions for the battlefield and transform military and public health through innovative...
The University of Queensland in Australia was awarded a $520,011 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from August 1, 2022 to July 31, 2025 on a novel mediator of cholangiocarcinoma that has potential as a diagnostic and treatment target. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
The U.S. Department of Defense's Defense Health Agency has awarded a $466,234 Project Grant to the University of Queensland in Australia to conduct "PROOF-OF-CONCEPT STUDIES FOR A NOVEL IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER AND COMPANION DIAGNOSTIC." This research grant, funded through the Military Medical Research and Development program (CFDA 12.420), aims to develop innovative treatments and diagnostic tools to improve care for military service members, veterans, and their...
The University of Sydney was awarded a $632,080 project grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on July 1, 2025, will support research investigating "What endows women with a better chance of survival from melanoma?" over a project period ending on June 30, 2028. This research aims to transform healthcare for military service members, veterans, and the broader public by advancing...